Jazz Pharmaceuticals plc - FORM 10-K - EX-23.1 - CONSENT OF INDEPENDENT REGISTERED PUBLIC ACCOUNTING FIRM. - March 3, 2010

Attached files

file filename
10-K - FORM 10-K - Jazz Pharmaceuticals plcd10k.htm
EX-32.1 - CERTIFICATION OF CEO AND PFO PURSUANT TO 18 U.S.C. SECTION 1350 - Jazz Pharmaceuticals plcdex321.htm
EX-12.1 - RATIO OF EARNINGS TO FIXED CHARGES - Jazz Pharmaceuticals plcdex121.htm
EX-31.2 - CERTIFICATION OF PFO PURSUANT TO RULES 13A - 14(A) AND 15D - 14(A) - Jazz Pharmaceuticals plcdex312.htm
EX-31.1 - CERTIFICATION CEO PURSUANT TO RULES 13A - 14(A) AND 15D - 14(A) - Jazz Pharmaceuticals plcdex311.htm
EX-21.1 - SUBSIDIARIES OF THE REGISTRANT - Jazz Pharmaceuticals plcdex211.htm

EXHIBIT 23.1

Consent of Independent Registered Public Accounting Firm

We consent to the incorporation by reference in the Registration Statements (Form S-8 Nos. 333-143553, 333-150008 and 333-158242) pertaining to the 2003 Equity Incentive Plan, 2007 Equity Incentive Plan, 2007 Employee Stock Purchase Plan and 2007 Non-Employee Directors Stock Option Plan, and the Registration Statement (Form S-3 No. 333-151593) of Jazz Pharmaceuticals, Inc. and in the related Prospectus, of our report dated March 3, 2010, with respect to the consolidated financial statements and schedule of Jazz Pharmaceuticals, Inc. included in this Annual Report (Form 10-K) for the year ended December 31, 2009.

 

/s/    ERNST & YOUNG LLP
Palo Alto, California
March 3, 2010

Stock widget

Investing forum

Jazz Pharmaceuticals plc Reports